Avedro, EyeGate Pharma to enter agreement

Article

EyeGate Pharma’s broad iontophoresis patent portfolio for corneal collagen cross-linking will be held as exclusive license by Avedro Inc. Delivery approach provides potential additional benefits to current formulation.

Recent Videos
© 2024 MJH Life Sciences

All rights reserved.